September 30, 2024
Mexico is among the countries with the highest firearm mortality rates. Although these rates decreased slightly between 2018 and 2022, firearm mortality remains a major public […]
September 30, 2024
TOPLINE: A fresh frozen plasma (FFP) to red blood cell (RBC) transfusion ratio above 1 is associated with decreased in-hospital mortality in patients with severe blunt […]
September 30, 2024
RIO DE JANEIRO — The addition of daratumumab to lenalidomide maintenance therapy following autologous stem cell transplant (ASCT) significantly improves rates of achieving minimal residual disease […]
September 30, 2024
The global withdrawal of voxelotor (Oxbryta, Pfizer) has left clinicians who treat sickle cell disease (SCD) with the urgent task of reaching patients taking the medicine, […]
September 29, 2024
Use of a modified sleep apnea index can identify cardiovascular risk factors in adults with moderate to severe obstructive sleep apnea (OSA), according to results from […]
September 27, 2024
TOPLINE: Maternal hepatitis C virus (HCV) infection is associated with a twofold increase in NICU admissions and nearly threefold increase in small-for-gestational-age births below the 5th […]
September 27, 2024
The Heart Failure Society of America (HFSA) has cancelled its annual scientific meeting, scheduled to begin today in Atlanta, Georgia, due to Hurricane Helene. “The safety […]
September 27, 2024
The US Food and Drug Administration (FDA) has approved Cobenfy (Bristol Myers Squibb), a first-in-class antipsychotic approved for schizophrenia. The drug targets cholinergic receptors as opposed […]
September 27, 2024
TOPLINE: Rates of sudden unexpected infant death (SUID) and sudden infant death syndrome (SIDS) increased during the COVID-19 pandemic, with the most significant rise observed in […]
Prev page
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438439440441442443444445446447448449450451452453454455456457458459460461462463464465466467468469470471472473474475476477478479480481482
Next page